Environnement, Risques & Santé


Biosurveillance des mycotoxines dans le plasma des patients atteints de la maladie d’Alzheimer et de la maladie de Parkinson Volume 21, issue 3, Mai-Juin 2022


This news is based on the following article: Arce-Lopez B, Alvarez-Erviti L, De Santis B, et al. Biomonitoring of mycotoxins in plasma of patients
with Alzheimer’s and Parkinson’s disease. Toxins 2021 ; 13 : 477. Doi : 10.3390/toxins13070477.


Neurodegenerative diseases are among the most frequent illnesses associated with aging, with Alzheimer disease the most common and Parkinson’s disease in second place. Despite extensive research, the causal mechanism for most cases of both remains unknown. Specific environmental factors, such as the biotoxins produced by bacteria, molds, and viruses, may be linked to the onset and progression of these disorders. Here the authors seek to determine real exposure to mycotoxins and thereby advance knowledge of the association between these diseases and this exposure.